Order results by:
Issue | Title | |
Vol 5, No 1 (2012) | COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS | Abstract similar documents |
R. I. Yagudina, I. Yu. Zinchuk, M. M. Litvinenko | ||
Vol 7, No 2 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract similar documents |
A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin | ||
"... Abstract: we have performed the first-ever comparative pharmacoeconomic analysis in a Russian ..." | ||
Vol 6, No 2 (2013) | PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION | Abstract similar documents |
V. A. Chibilyaev, A. Yu. Kulikov, R. I. Yagudina | ||
"... Comparative pharmacoeconomic analysis of two therapeutic strategy (the strategy A and the strategy ..." | ||
Vol 6, No 1 (2013) | THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION | Abstract similar documents |
A. Yu. Kulikov, Yu. L. Akimova | ||
"... In this paper gradually showed features of the methodology for conducting of pharmacoeconomics ..." | ||
Vol 6, No 1 (2013) | PHARMACOECONOMIC STUDY OF SKIN TESTS IN THE DIAGNOSTICS OF TUBERCULOSIS INFECTION | Abstract similar documents |
R. I. Yagudina, I. Yu. Zinchuk | ||
"... To provide pharmacoeconomic evaluation of diagnostics of tuberculosis infection (TI) with Allergen ..." | ||
Vol 8, No 3 (2015) | COMPARATIVE PHARMACOECONOMIC STUDY OF VITAMIN-MINERAL COMPLEXES FOR REHABILITATION DURING THE PERIOD OF INCREASED NEEDS FOR MICRONUTRIENTS | Abstract similar documents |
A. Yu. Belinskaya, I. Yu. Torshin, T. R. Grishina, O. A. Gromova | ||
"... Objective. To conduct a pharmacoeconomic analysis is required to select an optimal vitamin ..." | ||
Vol 10, No 2 (2017) | COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS | Abstract similar documents |
M. B. Kubaeva, Y. Sh. Guchshina | ||
"... The aim of our study was to conduct a pharmacoeconomic and cost analysis of the therapeutic use ..." | ||
Vol 6, No 4 (2013) | Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital | Abstract similar documents |
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
"... for the first time in the Russian conditions the pharmacoeconomic analysis examined ..." | ||
Vol 5, No 1 (2012) | PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING | Abstract similar documents |
M. V. Protsenko, N. I. Koroleva | ||
"... A properly conducted pharmacoeconomic study and its results are a new element in the body ..." | ||
Vol 11, No 1 (2018) | CYP2D6 genotyping in the daily routine of a psychiatric hospital – pharmacoeconomic evaluation | Abstract similar documents |
A. A. Kurylev, B. V. Andreev, A. S. Kolbin, O. V. Limankin | ||
"... are not well studied. Aim.To evaluate the pharmacoeconomic benefits of CYP2D6 polymorphisms genotyping ..." | ||
Vol 7, No 3 (2014) | PHARMACOECONOMIC ANALYSIS OF THE USE OF OXALIPLATIN CHEMOTHERAPY FOR COLORECTAL CANCER.REAL (ACTUAL) CLINICAL PRACTICE DATA | Abstract similar documents |
A. V. Pavlysh, A. S. Kolbin, A. R. Kasimova | ||
"... . Pharmacoeconomic analysis of application of oxaliplatin in colorectal cancer was performed. Cost-effectiveness ..." | ||
Vol 7, No 2 (2014) | CLINICAL AND ECONOMIC EVALUATION OF IVABRADINE USE IN STABLE ANGINA IN TERMS OF REPUBLIC OF BELARUS HEALTH CARE SYSTEM | Abstract similar documents |
I. N. Kozhanova, I. S. Romanova, L. N. Gavrilenko, A. V. Patseev, M. M. Sachek | ||
"... is the optimum pharmacoeconomic acceptability in patients with stable angina and high heart rate (70 beats per ..." | ||
Vol 16, No 4 (2023) | Pharmacoeconomic study of fluorescent lymphography and radionuclide diagnostics methods for sentinel lymph node detection in breast cancer | Abstract similar documents |
E. P. Kulikov, M. V. Shomova, D. S. Titov, A. N. Demko, M. A. Maistrenko | ||
"... . According to the results of a pharmacoeconomic study, it is more economically profitable to detect SLN ..." | ||
Vol 10, No 3 (2017) | Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients | Abstract similar documents |
N. K. Mazina, P. V. Mazin | ||
"... the pharmacoeconomic aspects of using enzalutamide, cabazitaxel and abiraterone for the second-line therapy of CRPC ..." | ||
Vol 10, No 2 (2017) | PHARMACOECONOMIC EVALUATION OF POMALIDOMIDE (IMNOVID) FOR THE TREATMENT OF RECURRENT AND REFRACTORY MULTIPLE MYELOMA | Abstract similar documents |
M. Yu. Frolov, O. V. Shatalova | ||
"... помалидомид в перечень жизненно необходимых и важнейших лекарственных препаратов (ЖНВЛП) и программу ..." | ||
Vol 10, No 4 (2017) | PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION | Abstract similar documents |
M. Yu. Frolov, V. A. Rogov | ||
"... гемофилии А в РФ и выявить пути оптимизации уровня оказания помощи. Материалы и методы. Построена ..." | ||
Vol 7, No 1 (2014) | ECONOMIC ASSESSMENT OF MAGNESIUM DEFICIENCY CORRECTION FOR BASIC THERAPY EFFICACY OF UNCONTROLLED ASTHMA IN CHILDREN | Abstract similar documents |
V. I. Petrov, I. N. Shishimorov, O. V. Magnitskaya, Ju. V. Ponomareva | ||
"... the efficiency of basic therapy for achieving asthma control and possesses pharmacoeconomic benefits, reducing ..." | ||
Vol 10, No 1 (2017) | PERAMPANEL EFFECTIVENESS IN THE TREATMENT OF REFRACTERY PARTIAL ONSET EPILEPSY WITH OR WITHOUT SECONDARY GENERALIZATION: PHARMACOECONOMIC ANALYSIS FOR THE RUSSIAN FEDERATION HEALTH CARE SYSTEM | Abstract similar documents |
N. K. Mazina, I. V. Sheshunov, P. V. Мazin, Yu. V. Kislitsin, E. M. Markova | ||
"... уровень затрат при лечении перампанелом в условиях российского здравоохранения. Материалы и методы. Для ..." | ||
Vol 6, No 4 (2013) | Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia | Abstract similar documents |
R. I. Yagudina, I. Yu. Zinchuk | ||
"... FENOC установлено, что нет значимой разницы в эффективности лечения препаратами АИКК и Эптаког альфа у ..." | ||
Vol 6, No 3 (2013) | PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER | Abstract similar documents |
R. I. Yagudina, I. Yu. Zinchuk | ||
"... На основании клинического исследования BCIRG 001 (Martin M., Mackey J., Pienkowski T.) [7] в ..." | ||
Vol 18, No 2 (2025) | Pharmacoeconomic study of oral anticancer therapy: results of combined ABC/VEN and frequency analysis | Abstract similar documents |
J. A. Agafonova | ||
"... . Это создает серьезные экономические барьеры для систем здравоохранения по всему миру. В условиях ..." | ||
Vol 5, No 1 (2012) | PHA RMA COE CONOMI CAL EVALUATION OF MULTIPLE MYELOMA TREATMENT WITH REVLIMID (LENALIDOMIDE ) IN THE RUSSIAN FEDE RATION | Abstract similar documents |
R. Yagudina, A. Kulikov, B. Misikova | ||
"... Pharmacoeconomic evaluation of treatment of the second and third lines of multiple myeloma ..." | ||
Vol 11, No 4 (2018) | Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer | Abstract similar documents |
N. A. Avxentyev, A. S. Makarov, M. Yu. Frolov | ||
"... patients in Russia. The aim of the current study was to develop a pharmacoeconomic tool that calculates ..." | ||
Vol 8, No 1 (2015) | BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD | Abstract similar documents |
A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina | ||
"... Впервые в российских условиях был проведен анализ влияния на бюджет применения бендамустина в ..." | ||
Vol 9, No 3 (2016) | METHOD «COST-EFFECTIVENESS» IN EVALUETION OF ATIBIOTIC TREATMENT OF ACYTR OBSTRUCTIVE BRONCHITIS IN CHILDREN IN HOSPITAL | Abstract similar documents |
O. V. Zhukova, S. V. Kononova | ||
"... Study objective: pharmacoeconomic evaluation of cephalosporins, protected penicillins ..." | ||
Vol 11, No 3 (2018) | Economic barriers restraining the production of therapeutic recombinant human trypsin. Use of innovative technologies to overcome them | Abstract similar documents |
S. V. Ponomarenko | ||
"... , методах производства рекомбинантной протеазы, ее рынке и типах энзимотерапии был проведен в различных ..." | ||
Vol 16, No 2 (2023) | Pharmacoeconomic study of various treatment options for superficial vein thrombophlebitis of lower extremities | Abstract similar documents |
R. E. Kalinin, I. A. Suchkov, M. M. Uporov, D. S. Titov, M. Yu. Klishchenko | ||
"... . Pharmacoeconomic evaluation was carried out using cost-effectiveness analysis (CEA) by calculating ..." | ||
Vol 5, No 2 (2012) | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES | Abstract similar documents |
R. I. Yagudina, I. V. Sorokovikov | ||
"... pharmacoeconomic cost-utility analysis – CUA is at third place by popularity (10% of studies ..." | ||
Vol 12, No 2 (2019) | Comparative modeling of socio-economic burden among smokers, nonsmokers and former smokers | Abstract similar documents |
E. V. Radchenko, A. S. Kolbin | ||
"... Цель - оценка социально-экономического бремени табакокурения в Российской Федерации (РФ) за 2017 г ..." | ||
Vol 15, No 2 (2022) | Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis | Abstract similar documents |
O. S. Mikhaylova, A. V. Krikova | ||
"... for the treatment of cardiovascular diseases. Objective: to perform a pharmacoeconomic study of the treatment ..." | ||
Vol 16, No 4 (2023) | Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma | Abstract similar documents |
S. V. Nedogoda, A. S. Salasyuk, S. N. Avdeev, I. N. Barykina, V. O. Lutova, E. A. Popova | ||
"... Цель: оценить клинико-экономическую эффективность применения бенрализумаба в сравнении со ..." | ||
Vol 17, No 3 (2024) | Review of open libraries for pharmacoeconomic analysis in R environment | Abstract similar documents |
I. A. Lackman, R. I. Sladkov, V. M. Timiryanova | ||
"... pharmacoeconomic analysis. Material and methods. The selection of libraries used for pharmacoeconomic analysis ..." | ||
Vol 6, No 2 (2013) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS | Abstract similar documents |
A. Yu. Kulikov, V. G. Serpik | ||
"... Pharmacoeconomic study of treatment primary open-angle glaucoma with carbonic anhydrise inhibitors ..." | ||
Vol 9, No 1 (2016) | PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION | Abstract similar documents |
M. Yu. Frolov, V. A. Rogov | ||
"... Objective: to conduct a pharmacoeconomic analysis of lenvatinib (Lenvima) in advanced progressive ..." | ||
Vol 10, No 1 (2017) | EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS | Abstract similar documents |
M. Yu. Frolov, V. A. Rogov | ||
"... The aim of this study was to identify the most effective (in the clinical and pharmacoeconomic ..." | ||
Vol 12, No 4 (2019) | Pharmacoeconomic analysis of using cyclin-dependent kinase 4 and 6 inhibitors in the first line treatment of HR-positive HER2-negative advanced breast cancer | Abstract similar documents |
N. A. Avxentyev, E. V. Lubennikova, M. Yu. Frolov | ||
"... study is to conduct complex pharmacoeconomic evaluation of using CDK4/6 inhibitors palbociclib ..." | ||
Vol 5, No 3 (2012) | COST-UTILITY ANALYSIS PATIENTS WITH LOW BACK PAIN AFTER TREATMENT INTRAOSSEOUS BLOCKADES | Abstract similar documents |
M. V. Yakovlev, A. U. Kulikov, E. L. Sokov, I. E. Kornilova | ||
"... , физиотерапия). Анализировались прямые затраты в течение 12 месяцев наблюдения пациентов. Показатели качества ..." | ||
Vol 16, No 3 (2023) | Cost-effectiveness analysis of encorafenib and binimetinib combination as first-line treatment for metastatic or unresectable BRAF V600-mutated metastatic melanoma in Russia | Abstract similar documents |
N. A. Avxentyev, Yu. V. Makarova | ||
"... Цель: провести клинико-экономическую оценку применения комбинации «энкорафениб + биниметиниб» в ..." | ||
Vol 15, No 2 (2022) | Pharmacoeconomic analysis of using benralizumab for treatment of severe asthma in inpatient and outpatient settings | Abstract similar documents |
M. V. Zhuravleva, S. N. Avdeev, Yu. V. Gagarina, T. V. Marin | ||
"... Objective: evaluation of the pharmacoeconomic feasibility of using benralizumab in the form ..." | ||
Vol 15, No 1 (2022) | Pharmacoeconomic analysis of using Monofer in patients with iron deficiency anemia as part of the provision of medical care under the state guarantees program in the health care system of the Russian Federation | Abstract similar documents |
R. I. Yagudina, A. Yu. Kulikov, V. G. Serpik, O. A. Gromova, I. Yu. Torshin | ||
"... Objective: comparative pharmacoeconomic analysis of iron preparations for intravenous infusion ..." | ||
Vol 12, No 3 (2019) | Availability and Pharmacoeconomics of Insulin Therapy in Countries with the Largest Number of Diabetics | Abstract PDF (Eng) similar documents |
S. V. Ponomarenko | ||
"... aspects of diabetes and the pharmacoeconomics of insulin, it is advised to develop a modern management ..." | ||
Vol 16, No 2 (2023) | Pharmacoeconomic analysis of antiretroviral therapy regimes in the Syrian Arab Republic | Abstract similar documents |
Yu. Sh. Gushchina, А. Yu. Abramov, Y. J. Haitham | ||
"... funding in the Syrian Arab Republic (SAR), pharmacoeconomic study of antiretroviral therapy (ART) regimens ..." | ||
Vol 5, No 3 (2012) | PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | Abstract similar documents |
A. U. Kulikov, I. A. Komarov | ||
"... . Pharmacoeconomic evaluation of this pathology contributes to the improvement of approaches to treatment policy ..." | ||
Vol 11, No 2 (2018) | Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia | Abstract similar documents |
N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov | ||
"... . The aim of this study was to conduct a pharmacoeconomic comparison of nilotinib, dasatinib and bosutinib ..." | ||
Vol 5, No 2 (2012) | PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS | Abstract similar documents |
A. Yu. Kulikov, V. G. Serpikov | ||
"... pharmacoeconomic study of treatment primary open-angle glaucoma with combinations of prostaglandin ..." | ||
Vol 16, No 3 (2023) | Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study | Abstract similar documents |
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina | ||
"... Цель: оценить клинико-экономическую эффективность применения алектиниба в сравнении с лорлатинибом ..." | ||
Vol 14, No 2 (2021) | Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis | Abstract similar documents |
N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova | ||
"... and pharmacoeconomics to evaluate the widespread introduction of new anti-tuberculosis drugs (ATDs), taking into account ..." | ||
Vol 9, No 3 (2016) | EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS | Abstract similar documents |
N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova | ||
"... включения технологии (лекарственного препарата) в ограничительные перечни, а также определить приемлемую для ..." | ||
Vol 5, No 3 (2012) | SEARCH OF INFORMATION IN PHARMACOECONOMIC RESEARCH | Abstract similar documents |
R. I. Yagudina, I. V. Novikov, V. G. Serpik | ||
"... in pharmacoeconomic studies. Review of methods of critical evaluation of research is also provided. ..." | ||
Vol 5, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF THE PROPHYLAXIS OF POSTSURGICAL INFECTIOUS INFLAMMATORY COMPLICATIONS OF COMBINED ANTIBIOTIC DRUGS AND CORTICOSTEROIDS IN OPHTHALMIC PRACTICE IN RUSSIAN FEDERATION | Abstract similar documents |
V. G. Serpik, R. I. Yagudina | ||
"... Pharmacoeconomic evaluation of postsurgical infectious inflammatory complications prophylaxis ..." | ||
1 - 50 of 68 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)